This study aimed to assess the prevalence of metabolic syndrome (MetS) and the association of years since menopause with MetS and Insulin Resistance (IR) in Chinese women.
Method:
A total of 4436 Chinese subjects aged 40–80 years participated in the study; 790 were premenopausal women, and 3646 were postmenopausal women. IR was arbitrarily defined as a homeostasis model assessment-IR index (HOMA-IR) value above the 75th percentile of normal glucose tolerance (NGT). MetS was defined according to the International Diabetes Federation consensus definition. To test whether there was an association between the number of years since menopause and MetS, multivariate logistic analysis was conducted. Premenopausal women were used as a comparison group in regression analyses.
Results:
After adjustment for age, body mass index (BMI), and γ-glutamyltransferase (GGT), more years since menopause was highly associated with an increased risk of MetS (p for trend <0.05) ; the number of years since menopause was not correlated with fasting insulin and HOMA-IR. Postmenopausal women with 10 to 14 years since menopause had the highest risk (odds ratio [OR], 2.10; 95% confidence interval [CI], 1.52–2.89, p < .05) of MetS, high triglycerides (TG; OR, 1.80; 95% CI, 1.34–2.42, p < .05) and high glucose (OR, 1.52; 95% CI, 1.14–2.05, p < .05) and low high-density lipoprotein cholesterol (HDL-C; OR, 1.38; 95% CI, 1.18–2.32, p < .05). Postmenopausal women with more than 15 years since menopause had the highest risk of abdominal obesity (OR, 1.69; 95% CI, 1.05–2.71, p < .05).
Conclusion:
In China, more years since menopause was highly associated with an increased risk of MetS. Menopausal history may help identify women with increased risk of developing MetS.
Get full access to this article
View all access options for this article.
References
1.
AlbertiKG, ZimmetP, ShawJ, IDF Epidemiology Task Force Consensus Group: The Metabolic Syndrome–a New Worldwide Definition. Lancet, 2005; 366:1059–1062.
2.
AmigoniS, MorelliP, ParazziniF, ChatenoudL: Determinants of elevated blood pressure in women around menopause: Results from a cross-sectional study in Italy. Maturitas, 2000; 34:25–32.
3.
AziziF, SalehiP, EtemadiA, Zahedi-AslS, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract, 2003; 61:29–37.
4.
BardiniG, DicembriniI, RotellaCM, GianniniS: Correlation between Hdl cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. Acta Diabetol, 2013; 50:277–281.
5.
BrunhamLR, KruitJK, VerchereCB, HaydenMR, Cholesterol in islet dysfunction and Type 2 Diabetes. J Clin Invest, 2008; 118:403–408.
6.
CatalanoD, TrovatoGM, SpadaroD, MartinesGF, et al.: Insulin resistance in postmenopausal women: Concurrent effects of hormone replacement therapy and coffee. Climacteric, 2008; 11:373–382.
7.
ChoGJ, LeeJH, ParkHT, ShinJH, et al.: Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause, 2008; 15:524–529.
8.
ColditzGA, StampferMJ, WillettWC, StasonWB, et al.: Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol, 1987; 126:319–325.
9.
DallongevilleJ, MarecauxN, IsorezD, ZylbergbergG, et al.: Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis, 1995; 118:123–133.
10.
EspositoK, ChiodiniP, CapuanoA, BellastellaG, et al.: Metabolic syndrome and postmenopausal breast cancer: Systematic review and meta-analysis. Menopause, 2013; 20:1301–1309.
11.
FordES, GilesWH, DietzWH: Prevalence of the metabolic syndrome among us adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA, 2002; 287:356–359.
12.
GaspardU: Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women Maturitas. 2009; 62:362–365.
13.
Graff-IversenS, ThelleDS, HammarN: Serum lipids, blood pressure and body weight around the age of the menopause. Eur J Cardiovasc Prev Rehabil, 2008; 15:83–88.
14.
Italia Gruppo di Studio Progetto Menopausa: Risk factors for high blood pressure in women attending menopause clinics in Italy. Maturitas, 2006; 53:83–88.
15.
HaffnerSM, KatzMS, SternMP, DunnJF: The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism, 1988; 37:683–688.
KalyaniRR, FrancoM, DobsAS, OuyangP, et al.: The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab, 2009; 94:4127–4135.
18.
LeeJS, HayashiK, MishraG, YasuiT, KubotaT, MizunumaH: Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study. J Atheroscler Thromb, 2013; 20:161–169.
19.
LemayA, TurcotL, DecheneF, DodinS, ForestJC: Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: A useful early measure of susceptibility to insulin resistance. Menopause, 2010; 17:321–325.
20.
LisabethLD, BeiserAS, BrownDL, MurabitoJM, et al.: Age at natural nenopause and risk of ischemic stroke: The Framingham Heart Study Stroke. 2009; 40:1044–1049.
21.
LofgrenI, GreeneG, SchembreS, DelmonicoMJ, et al.: Comparison of diet quality, physical activity and biochemical values of older adults either reporting or not reporting use of lipid-lowering medication. J Nutr Health Aging, 2010; 14:168–172.
22.
ManZW, ZhuM, NomaY, ToideK, et al.: Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in oletf rat, a model of spontaneous niddm. Diabetes, 1997; 46:1718–1724.
23.
MeigsJB, WilsonPW, FoxCS, VasanRS, et al.: Body mass index, metabolic syndrome, and risk of Type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab, 2006; 91:2906–2912.
24.
NingG, Group Reaction Study: Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (reaction) study. J Diabetes, 2012; 4:172–173.
25.
NordinBE, NeedAG, ChattertonBE, HorowitzM, MorrisHA: The relative contributions of age and years since menopause to postmenopausal bone loss. J Clin Endocrinol Metab, 1990; 70:83–88.
26.
PoehlmanET, TothMJ, GardnerAW: Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med, 1995; 123:673–675.
27.
RuanX, JinJ, HuaL, LiuY, WangJ, LiuS: The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it. Menopause, 2010; 17:566–570.
28.
RuttiS, EhsesJA, SiblerRA, PrazakR, et al.: Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology, 2009; 150:4521–4530.
29.
SchiancaGP, CastelloL, RapettiR, LimonciniA, BartoliE: Insulin sensitivity: Gender-related differences in subjects with normal glucose tolerance. Nutr Metab Cardiovasc Dis, 2006; 16:339–344.
30.
ShiH, CleggDJ: Sex differences in the regulation of body weight. Physiol Behav, 2009; 97:199–204.
31.
SteinbergerJ, DanielsSR, EckelRH, HaymanL, et al.: Progress and challenges in metabolic syndrome in children and adolescents. A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2009; 119:628–647.
32.
TamakoshiK, YatsuyaH, WadaK, MatsushitaK, et al.: The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol (Oxf), 2007; 66:65–71.
33.
TremollieresFA, PouillesJM, RibotCA: Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol, 1996; 175:1594–1600.
34.
TripathyD, AlmgrenP, TuomiT, GroopL: Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care, 2004; 27:2204–2210.
35.
VillegasR, PerryIJ, CreaghD, HinchionR, O'HalloranD: Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care, 2003; 26:3198–3199.
36.
WangJJ, HuG, LappalainenJ, MiettinenME, QiaoQ, TuomilehtoJ: Changes in features of the metabolic syndrome and incident impaired glucose regulation or Type 2 diabetes in a Chinese population. Diabetes Care, 2005; 28:448–450.
37.
ZhangM, BinnsCW, LeeAH: Dietary patterns and nutrient intake of adult women in South-East China: A nutrition study in Zhejiang Province. Asia Pac J Clin Nutr, 2002; 11:13–21.
38.
ZhengZ, ZhangC, YanJ, RuanY, et al.: Diabetes mellitus is associated with hepatocellular carcinoma: A retrospective case-control study in hepatitis endemic area. PLoS One, 2013; 8:e84776.
39.
ZhouJL, LinSQ, ShenY, ChenY, et al.: Serum lipid profile changes during the menopausal transition in Chinese women: A community-based cohort study. Menopause, 2010; 17:997–1003.
40.
ZhouYP, BerggrenPO, GrillV: A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic Db/Db mouse. Diabetes, 1996; 45:580–586.
